Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Aileron Therapeutics Inc (ALRN) PT Lowered to $5 at Canaccord Genuity
-
Aileron Therapeutics Reports Second Quarter 2018 Financial Results
-
Aileron Therapeutics Reports Second Quarter 2018 Financial Results
-
Aileron Therapeutics to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Aileron Therapeutics to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Aileron Therapeutics Reports First Quarter 2018 Financial Results
-
Aileron Therapeutics Reports First Quarter 2018 Financial Results
-
Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
-
Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
-
Aileron Therapeutics to Present at Canaccord Genuity 37th Annual Growth Conference
-
Canaccord Genuity Starts Aileron Therapeutics Inc (ALRN) at Buy
-
Aileron Therapeutics (ALRN) IPO Opens Lower
-
American Learning Corp (ALRN) Prices 3.75M Share IPO at $15/Sh
-
Aileron Therapeutics Announces Pricing of Initial Public Offering

